CRNX Q1 2026 Earnings Narrowed Loss Per Share Slightly Below Expectations Traws Pharma Q1 2026 Earnings Narrower Than Expected Loss Despite No Revenue MaxLinear Q1 2026 Earnings EPS Beats Estimates Despite Revenue Uncertainty RRX Q1 2026 Earnings EPS Beats Estimates as Margins Improve Stock Slides ELVN Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline EIC Q4 2025 Earnings Narrow EPS Miss Amid Steady Performance